Trial intelligence / Profile preview

Effect of L-carnitine on transplanted liver function

IRCT20100111003043N12Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of levocarnitine in liver transplant, sponsored by Tehran University of Medical Sciences. Started Jun 2018; status: completed.

02

Drugs

levocarnitine
03

Conditions

liver transplant

Beyond the preview

Go deeper on IRCT20100111003043N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100111003043N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call